These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Squalamine improves retinal neovascularization. Higgins RD, Sanders RJ, Yan Y, Zasloff M, Williams JI. Invest Ophthalmol Vis Sci; 2000 May; 41(6):1507-12. PubMed ID: 10798670 [Abstract] [Full Text] [Related]
3. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M. Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024 [Abstract] [Full Text] [Related]
4. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB. Curr Eye Res; 1999 Jan; 18(1):20-7. PubMed ID: 10075199 [Abstract] [Full Text] [Related]
5. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy. Vessey KA, Wilkinson-Berka JL, Fletcher EL. J Comp Neurol; 2011 Feb 15; 519(3):506-27. PubMed ID: 21192081 [Abstract] [Full Text] [Related]
6. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model. Liu X, Wang D, Liu Y, Luo Y, Ma W, Xiao W, Yu Q. Invest Ophthalmol Vis Sci; 2010 Jul 15; 51(7):3749-57. PubMed ID: 20207957 [Abstract] [Full Text] [Related]
7. CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity. Ludewig P, Flachsbarth K, Wegscheid C, Tiegs G, Richard G, Wagener C, Bartsch U, Horst AK. Invest Ophthalmol Vis Sci; 2014 Nov 18; 55(12):7950-60. PubMed ID: 25406283 [Abstract] [Full Text] [Related]
8. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Neu J, Afzal A, Pan H, Gallego E, Li N, Li Calzi S, Caballero S, Spoerri PE, Shaw LC, Grant MB. Invest Ophthalmol Vis Sci; 2006 Jul 18; 47(7):3151-5. PubMed ID: 16799062 [Abstract] [Full Text] [Related]
9. An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy. Wilkinson-Berka JL, Lofthouse S, Jaworski K, Ninkovic S, Tachas G, Wraight CJ. Mol Vis; 2007 Aug 29; 13():1529-38. PubMed ID: 17893652 [Abstract] [Full Text] [Related]
10. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity. Rabinowitz R, Priel A, Rosner M, Pri-Chen S, Spierer A. Curr Eye Res; 2012 Jul 29; 37(7):624-9. PubMed ID: 22578253 [Abstract] [Full Text] [Related]
11. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy. Franklin AJ, Jetton TL, Kuchemann CL, Russell SR, Kohn EC. Invest Ophthalmol Vis Sci; 2004 Oct 29; 45(10):3756-66. PubMed ID: 15452087 [Abstract] [Full Text] [Related]
12. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy. Fang X, Ueno M, Yamashita T, Ikuno Y. Curr Eye Res; 2011 Nov 29; 36(11):1028-36. PubMed ID: 21999228 [Abstract] [Full Text] [Related]
13. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat. van Wijngaarden P, Brereton HM, Gibbins IL, Coster DJ, Williams KA. Exp Eye Res; 2007 Oct 29; 85(4):508-17. PubMed ID: 17692314 [Abstract] [Full Text] [Related]
17. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity. Hatzopoulos KM, Vessey KA, Wilkinson-Berka JL, Fletcher EL. Invest Ophthalmol Vis Sci; 2014 Jun 03; 55(6):3957-70. PubMed ID: 24894399 [Abstract] [Full Text] [Related]